EUROPE

How we help

With more than €35m invested each year in R&D, and accounting for around 20% of all pharmaceutical sales, Europe remains a critical market for the pharmaceutical industry.

However, it’s also a complex market.

Made up of 50 countries, 27 EU member states and a multitude of languages, success for a pharmaceutical or biotech company requires an in-depth understanding of regulations and market dynamics.

It requires strong infrastructure and resource to optimise the supply of important medicines for both research and treatment.

It requires longstanding relationships with healthcare professionals, hospitals, pharmacies, regulatory bodies and suppliers.

That’s where Clinigen comes in.

With more than 250 employees across sites in Germany, France, Belgium and Ireland, including key account managers, marketing specialists and Medical Science Liaisons, Clinigen ensure healthcare professionals in every European country can access the right medicines.

Clinigen’s expert regulatory teams work with competent authorities to supply medicines to clinical, unlicensed and licensed markets. Specialist capabilities, including ambient and cold chain solutions, direct-to-patient shipping and on-demand packaging and labelling, mean that patients receive the treatments they need quickly and safely.

Get in touch to find out more about how Clinigen can help.